Top Healthcare companies in Denmark by Return on Assets (ROA)
Denmark
# |
Name |
Return on Assets (ROA) |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
26.61%
|
Dec. 31, 2023 | USD 81.94 | -2.80% |
|
Denmark |
|
| 2 |
12.33%
|
Dec. 31, 2023 | USD 190.39 | -3.71% |
|
Denmark |
|
| 3 |
10.28%
|
Dec. 31, 2023 | USD 25.56 | -6.78% |
|
Denmark |
|
| 4 |
7.46%
|
Sept. 30, 2023 | USD 0.73 | -11.55% |
|
Denmark |
|
| 5 |
6.12%
|
Dec. 31, 2023 | USD 6.01 | -1.79% |
|
Denmark |
|
| 6 |
3.28%
|
Sept. 30, 2024 | USD 18.27 | -2.30% |
|
Denmark |
|
| 7 |
-7.12%
|
Dec. 31, 2023 | USD 88.54 | -3.65% |
|
Denmark |
|
| 8 |
-35.54%
|
Dec. 31, 2023 | USD 96.67 | -5.32% |
|
Denmark |
|
| 9 |
-58.32%
|
Dec. 31, 2023 | USD 130.66 | 2.64% |
|
Denmark |
|
| 10 |
-62.72%
|
Dec. 31, 2023 | USD 0.20 | -4.20% |
|
Denmark |
|
| 11 |
-116.15%
|
Dec. 31, 2023 | USD 2.61 | -4.99% |
|
Denmark |
|
| 12 |
-149.37%
|
Dec. 31, 2023 | USD 0.73 | 4.37% |
|
Denmark |
|
| 13 |
-171.66%
|
Dec. 31, 2023 | USD 2.46 | -0.40% |
|
Denmark |
Frequently Asked Questions
-
Which Healthcare company in Denmark has the highest Return on Assets (ROA) ?
The Healthcare company in Denmark with the highest Return on Assets (ROA) is Novo Nordisk A/S (Copenhagen Stock Exchange: NOVO-B.CO) at 26.61%.
-
Which Healthcare company in Denmark has the lowest Return on Assets (ROA) ?
The Healthcare company in Denmark with the lowest Return on Assets (ROA) is Evaxion Biotech A/S (NasdaqCM: EVAX) at -171.66%.
-
What are the top 10 Healthcare companies in Denmark by Return on Assets (ROA) ?
The top 10 Healthcare companies in Denmark by Return on Assets (ROA) are Novo Nordisk A/S, Genmab A/S, Bavarian Nordic A/S, Scandinavian Medical Solutions A/S, H. Lundbeck A/S, Ambu A/S, Gubra A/S, Zealand Pharma A/S, Ascendis Pharma A/S and BioPorto A/S.
-
What are the bottom 10 Healthcare companies in Denmark by Return on Assets (ROA) ?
The bottom 10 Healthcare companies in Denmark by Return on Assets (ROA) are Evaxion Biotech A/S, Saniona AB (publ), ExpreS2ion Biotech Holding AB (publ), BioPorto A/S, Ascendis Pharma A/S, Zealand Pharma A/S, Gubra A/S, Ambu A/S, H. Lundbeck A/S and Scandinavian Medical Solutions A/S.
